Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Toripalimab Combined With Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma

NCT04405622 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT04405622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04405622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Toripalimab Combined With Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma
Lead sponsor
Sun Yat-sen University
Phase
Phase 2
Overall status
Unknown status
Start date
May 30, 2020
Completion date
May 31, 2023
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, immunotherapy, metastatic nasopharyngeal carcinoma, nasopharyngeal carcinoma, recurrent nasopharyngeal carcinoma